Aptar Q2 FY26 EPS drops 19% to $1.36; net sales rise 6% to $1.03 billion

• AptarGroup Q2 net income fell to $88 million; diluted EPS dropped to $1.36 as net sales rose 6% to $1.03 billion.
• Adjusted EBITDA margin narrowed to 20.7% from 22.6%; adjusted diluted EPS declined to $1.42.
• Pharma net sales climbed 4%, Beauty rose 10%, Closures increased 7%; all three segments posted lower adjusted EBITDA margins.
• Management said emergency medicine destocking weighed on Pharma; expects the headwind to abate by Q4.
• Forecasts Q3 adjusted EPS of $1.45-$1.53; returned $81 million to shareholders via buybacks and dividends.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AptarGroup Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202607301700BIZWIRE_USPR_____20260730_BW133160) on July 30, 2026, and is solely responsible for the information contained therein.